Meal replacement system for Diabetes Mellitus, Type 2
Phase-Based Progress Estimates
Effectiveness
Safety
Loma Linda University Health, Loma Linda, CA
Diabetes Mellitus, Type 2+2 More
Meal replacement system - DietarySupplementEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is testing a meal replacement system to see if it can help people with Type 2 Diabetes go into remission without the use of medications. In this trial, patients with diabetes will be given a meal replacement system in order to treat their condition. This is not a placebo-based trial, so all patients will receive the treatment. The meal replacement system has been previously approved by the FDA for another condition.
Eligible Conditions
- Diabetes Mellitus, Type 2
- Obesity
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: Change between baseline and six month visit.
Change between baseline and six month visit.
Efficacy of plant-based meal replacement system on A1-C levels
Efficacy of plant-based meal replacement system on insulin levels
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Standard of Care Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment
50 Total Participants · 2 Treatment Groups
Primary Treatment: Meal replacement system · No Placebo Group · N/A
Intervention GroupExperimental Group · 2 Interventions: Meal replacement system, Intensive lifestyle Intervention · Intervention Types: DietarySupplement, Behavioral
Standard of Care GroupNoIntervention Group · 1 Intervention: Standard of Care Group · Intervention Types:
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change between baseline and six month visit.
Closest Location: Loma Linda University Health · Loma Linda, CA
2010First Recorded Clinical Trial
1 TrialsResearching Diabetes Mellitus, Type 2
13 CompletedClinical Trials
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
281 Previous Clinical Trials
257,090 Total Patients Enrolled
5 Trials studying Diabetes Mellitus, Type 2
56,240 Patients Enrolled for Diabetes Mellitus, Type 2
Warren Peters, MDPrincipal InvestigatorLoma Linda University Health
1 Previous Clinical Trials
100 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are a man or woman.
You have been diagnosed with diabetes for less than five years.
You are taking at least one oral agents for diabetes.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments